Oliver Fitzgerald

Oliver Fitzgerald

UNVERIFIED PROFILE

Are you Oliver Fitzgerald?   Register this Author

Register author
Oliver Fitzgerald

Oliver Fitzgerald

Publications by authors named "Oliver Fitzgerald"

Are you Oliver Fitzgerald?   Register this Author

100Publications

3111Reads

15Profile Views

PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.

J Rheumatol 2019 Aug 15;46(8):990-995. Epub 2018 Dec 15.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore; Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Kezar Life Sciences, South San Francisco; Division of Immunology, Stanford University, Palo Alto, California; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Global Patient Outcomes and Real World Evidence, Eli Lilly and Co., Indianapolis, Indiana; University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Royal National Hospital for Rheumatic Diseases, Bath; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; Musculoskeletal Statistics Unit: The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Sorbonne Université; Rheumatology Department, Pitié Salpêtrière Hospital, AP-HP, Paris, France; VU Medical Centre, Amsterdam, the Netherlands; Global Medical Affairs, Pfizer Inc., Montreal, Quebec; Clinical Epidemiology Program, Ottawa Hospital Research Institute; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, Institute for Health Policy Management and Evaluation, University of Toronto; University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181077DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571063PMC
August 2019

Endorsement of the 66/68 Joint Count for the Measurement of Musculoskeletal Disease Activity: OMERACT 2018 Psoriatic Arthritis Workshop Report.

J Rheumatol 2019 Aug 15;46(8):996-1005. Epub 2019 Feb 15.

From the Division of Rheumatology, Department of Medicine, and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota; Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Rheumatology, Duke University School of Medicine, Durham, North Carolina; Kezar Life Sciences, South San Francisco; Amgen Inc., Thousand Oaks, California; Swedish-Providence-St. John's Health Systems and University of Washington, Seattle, Washington; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore; University of Leeds, Leeds; University of Oxford, Oxford; Royal National Hospital for Rheumatic Diseases; University of Bath, Bath, UK; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital; Institute for Work and Health; Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute and the Institute for Health Policy Management and Evaluation, University of Toronto; Department of Medicine, University of Toronto, Women's College Hospital; Department of Medicine, University of Toronto, Toronto Western Hospital, Toronto; Cochrane Musculoskeletal Group, Ottawa Hospital Research Institute, Centre for Practice-Changing Research; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario; Pfizer Inc., Montreal, Quebec, Canada; Musculoskeletal Statistics Unit: The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen; Department of Rheumatology, Odense University Hospital, Odense, Denmark; Department of Medical Humanities, Patient Research Partner, Amsterdam University Medical Centre, Amsterdam, the Netherlands; Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Ireland; Royal Prince Alfred Hospital Medical Centre, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.181089DOI Listing
August 2019

Inflammatory back pain criteria perform well in subset of patients with active axial psoriatic arthritis but not among patients with established axial disease.

Ann Rheum Dis 2019 Jul 14;78(7):1003-1004. Epub 2018 Dec 14.

Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2018-214583DOI Listing
July 2019

Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and Research (PEER) meeting.

Semin Arthritis Rheum 2019 Jun 15;48(6):1005-1013. Epub 2018 Oct 15.

St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin School of Medicine, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2018.10.008DOI Listing
June 2019

Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2019 Jun;95:11-19

From the Rheumatology Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto; Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Swedish Medical Center/Providence-St. Joseph Health, Seattle, Washington; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Conway Institute for Biomolecular Research, University College Dublin; Our Lady's Hospice and Care Services; Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Department of Medical Humanities, Amsterdam University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190118DOI Listing
June 2019

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 Annual Meeting: Report and Plan for Completing the Core Outcome Measurement Set.

J Rheumatol Suppl 2019 Jun;95:33-37

From the Duke-NUS Medical School, Singapore; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Department of Dermatology, University of Utah, Salt Lake City, Utah; Kezar Life Sciences, San Francisco; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California; Duke University School of Medicine, Durham, North Carolina; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford; Royal National Hospital for Rheumatic Diseases, University of Bath, Bath, UK; Amsterdam University Medical Centre, Department of Medical Humanities, Amsterdam, the Netherlands; Women's College Research Institute, Women's College Hospital, Department of Medicine, University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190122DOI Listing
June 2019

GRAPPA 2018 Project Report.

J Rheumatol Suppl 2019 Jun;95:54-57

From Kezar Life Sciences, San Francisco, California; Duke University School of Medicine, Durham, North Carolina, USA; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto; Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada; UK National Institute for Health Research (NIHR), Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals UK National Health Service (NHS) Foundation Trust, Bradford, UK; University of California at San Diego, La Jolla, California, USA; University of Alberta, Edmonton, Alberta, Canada; Rheumatology Research, Swedish Medical Center; University of Washington School of Medicine, Seattle, Washington, USA; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.190121DOI Listing
June 2019

Using Acute-phase Reactants to Inform the Development of Instruments for the Updated Psoriatic Arthritis Core Outcome Measurement Set.

J Rheumatol 2019 Mar 1;46(3):266-273. Epub 2018 Nov 1.

From the Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Division of Rheumatology, University of Toronto, Krembil Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology and Immunology, Singapore General Hospital; Duke-NUS Medical School, Singapore; University Hospitals, Cleveland, Ohio, USA; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, Maryland, USA; Women's College Research Institute, Women's College Hospital; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180195DOI Listing
March 2019

Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab.

J Rheumatol 2019 Mar 1. Epub 2019 Mar 1.

From the Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada; Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland; Division of Rheumatology, Allergy, and Immunology, University of California, San Diego School of Medicine, La Jolla, San Diego, California, USA; Pfizer Inc., Groton, Connecticut, USA; Pfizer Inc., Montreal, Quebec, Canada. This study was funded by Pfizer Inc., which manufactures tofacitinib. DDG has received research grants and consultancy fees from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc., and UCB, and has received consultancy fees from AbbVie, Amgen, Bristol-Myers Squibb, Celgene, Eli Lilly, Janssen, Novartis, Pfizer Inc., and UCB. OF has received research grants from AbbVie, Bristol-Myers Squibb, Novartis, and Pfizer Inc. DG, CW, and LF are employees and shareholders of Pfizer Inc. Pfizer Inc. was involved in the design of the study, collection, analysis, and interpretation of data, and review and approval of the manuscript. D. van der Heijde, MD, Department of Rheumatology, Leiden University Medical Center; D.D. Gladman, MD, Department of Rheumatology, University of Toronto, Toronto Western Hospital; O. FitzGerald, MD, Department of Rheumatology, St. Vincent's University Hospital; A. Kavanaugh, MD, Division of Rheumatology, Allergy, and Immunology, University of California, San Diego School of Medicine; D. Graham, MD, Pfizer Inc., Groton, Connecticut; C. Wang, PhD, Pfizer Inc., Groton; L. Fallon, PhD, Pfizer Inc., Montreal. Address correspondence to Prof. D. van der Heijde, Department of Rheumatology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, the Netherlands. E-mail: Full Release Article. For details see Reprints and Permissions at jrheum.org. Accepted for publication November 21, 2018.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180971DOI Listing
March 2019

Comprehensive characterisation of the heterogeneity of adalimumab via charge variant analysis hyphenated on-line to native high resolution Orbitrap mass spectrometry.

MAbs 2019 01 11;11(1):116-128. Epub 2018 Nov 11.

a Characterisation and Comparability Lab , NIBRT - The National Institute for Bioprocessing Research and Training , Co , Dublin , Ireland.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/19420862.2018.1
Publisher Site
http://dx.doi.org/10.1080/19420862.2018.1531664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343805PMC
January 2019

Clinical Features of Psoriatic Arthritis: a Comprehensive Review of Unmet Clinical Needs.

Clin Rev Allergy Immunol 2018 Dec;55(3):271-294

Conway Institute of Biomedical Research, University College Dublin, Dublin, 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12016-017-8630-7DOI Listing
December 2018

Advanced musculoskeletal physiotherapy practice in Ireland: A National Survey.

Musculoskeletal Care 2018 12 21;16(4):425-432. Epub 2018 Jun 21.

School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/msc.1351DOI Listing
December 2018

Remission in psoriatic arthritis-where are we now?

Rheumatology (Oxford) 2018 08;57(8):1321-1331

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and National Institute for Health Research (NIHR) Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex344DOI Listing
August 2018

Modifications of Cardiovascular Risk Scores, But Not Standard Risk Scores, Improve Identification of Asymptomatic Coronary Artery Disease in Psoriatic Arthritis.

J Rheumatol 2018 Aug;45(9):1329-1330

Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180299DOI Listing
August 2018

Content and Face Validity and Feasibility of 5 Candidate Instruments for Psoriatic Arthritis Randomized Controlled Trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting.

J Rheumatol Suppl 2018 Jun;94:17-25

From the Royal Prince Alfred Hospital Medical Centre, Sydney, Australia; Royal National Hospital for Rheumatic Diseases, Bath, UK; University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; University of Toronto, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; University of Oxford, Oxford, UK; Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto, Ontario, Canada; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA; Department of Rheumatology, St. Vincents University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; The Parker Institute, Bispebjerg and Frederiksberg Hospital, The Capital Region of Denmark; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; VU Medical Centre, Amsterdam, the Netherlands; IQVIA, Duke University School of Medicine, Durham, North Carolina, USA; School of Epidemiology, Public Health, and Preventive Medicine, Faculty of Medicine, University of Ottawa, and Ottawa Hospital Research Institute, Clinical Epidemiology Program, Ottawa, Ontario, Canada; Musculoskeletal Health and Outcomes Research, St. Michael's Hospital and Institute for Work and Health, and Department of Occupational Science and Occupational Therapy, Rehabilitation Sciences Institute, and the Institute for Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180142DOI Listing
June 2018

GRAPPA 2017 Project Report.

J Rheumatol Suppl 2018 Jun;94:48-51

From the University of Utah, Salt Lake City, Utah; University of California at San Diego, La Jolla, California; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; New York University School of Medicine, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin; Our Lady's Hospice and Care Services, Dublin, Ireland; Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180139DOI Listing
June 2018

Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting.

J Rheumatol Suppl 2018 Jun;94:54-61

From the Rheumatology Research Unit, Cambridge University Hospitals UK National Health Service (NHS) Foundation Trust, Cambridge; University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute, Toronto, Ontario, Canada; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Southern California, Los Angeles, California; University of Utah, Salt Lake City, Utah; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Our Lady's Hospice and Care Services; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Department of Medical Humanities, VU University Medical Centre, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.180141DOI Listing
June 2018

Advanced practice physiotherapy-led triage in Irish orthopaedic and rheumatology services: national data audit.

BMC Musculoskelet Disord 2018 Jun 1;19(1):181. Epub 2018 Jun 1.

School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12891-018-2106-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984783PMC
June 2018

Opportunities and challenges in the treatment of psoriatic arthritis.

Best Pract Res Clin Rheumatol 2018 06 25;32(3):440-452. Epub 2019 Apr 25.

Chief, Allergy, Immunology & Rheumatology Division, Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.berh.2019.03.001DOI Listing
June 2018

A new era for collaboration?

Rheumatology (Oxford) 2018 05;57(5):775-776

Department of Pharmacy and Pharmacology, University of Bath, Bath, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/kex083DOI Listing
May 2018

Higher Coronary Plaque Burden in Psoriatic Arthritis Is Independent of Metabolic Syndrome and Associated With Underlying Disease Severity.

Arthritis Rheumatol 2018 03 6;70(3):396-407. Epub 2018 Feb 6.

St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/art.40389DOI Listing
March 2018

Early interventions to promote work participation in people with regional musculoskeletal pain: a systematic review and meta-analysis.

Clin Rehabil 2017 Nov 27;31(11):1466-1481. Epub 2017 Mar 27.

1 Department of Psychology, Maynooth University, Maynooth, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0269215517699976DOI Listing
November 2017

Updating the Psoriatic Arthritis (PsA) Core Domain Set: A Report from the PsA Workshop at OMERACT 2016.

J Rheumatol 2017 Oct 1;44(10):1522-1528. Epub 2017 Feb 1.

From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Department of Dermatology, University of Utah, Salt Lake City, Utah; Quintiles, Duke University School of Medicine, Durham, North Carolina; Division of Immunology, Stanford University, Palo Alto, California; Cleveland Clinic, Cleveland, Ohio; University of Pennsylvania, Philadelphia, Pennsylvania, USA; VU Medical Centre, Amsterdam; Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands; Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Royal National Hospital for Rheumatic Diseases; Royal National Hospital for Rheumatic Diseases, Bath; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals UK National Health Service (NHS) Trust, Leeds, UK; Toronto Western Hospital; University of Toronto; Krembil Research Institute; Psoriatic Arthritis Program, University Health Network; Women's College Research Institute, Women's College Hospital, University of Toronto, Toronto; Ottawa Hospital Research Institute, School of Epidemiology, Public Health and Preventative Medicine, University of Ottawa, Ottawa, Ontario, Canada; Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark; Department of Rheumatology and Immunology, Singapore General Hospital, Singapore; Department of Internal Medicine, Division of Rheumatology, Hacettepe University, Ankara, Turkey.

View Article

Download full-text PDF

Source
http://www.jrheum.org/lookup/doi/10.3899/jrheum.160904
Publisher Site
http://dx.doi.org/10.3899/jrheum.160904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538953PMC
October 2017

Tofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis.

N Engl J Med 2017 10;377(16):1537-1550

From the Swedish Medical Center and University of Washington, Seattle (P.M.); Cabrini Health and Monash University, Melbourne, VIC, Australia (S.H.); the Department of Rheumatology, St. Vincent's University Hospital and Conway Institute of Biomolecular and Biomedical Research, University College, Dublin (O.F.); Leiden University Medical Center, Leiden, the Netherlands (D.H.); Brigham and Women's Hospital, Harvard Medical School, Boston (J.F.M.); Centro Multidisciplinario para el Desarrollo Especializado de la Investigación Clínica en Yucatán Sociedad Civil Privada, Merida, Mexico (F.A.-Z.); the Department of Rheumatology and Clinical Immunology, Medical University of Poznan, Poznan, Poland (D.C.); Pfizer, Groton, CT (D.G., C.W., S.M., K.S.K.); and Pfizer, Collegeville, PA (T.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1615975DOI Listing
October 2017

The Effect of Anterior Uveitis and Previously Undiagnosed Spondyloarthritis: Results from the DUET Cohort.

J Rheumatol 2017 Sep 1;44(9):1347-1354. Epub 2017 Jul 1.

From the Department of Ophthalmology, Royal Victoria Eye and Ear Hospital; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin; University Hospital Kerry, Tralee, Kerry, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170115DOI Listing
September 2017

Clinical and genetic associations of radiographic sacroiliitis and its different patterns in psoriatic arthritis.

Clin Exp Rheumatol 2017 Mar-Apr;35(2):270-276. Epub 2016 Dec 13.

Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
June 2017

Proceedings of the GRAPPA 2016 Retreat.

J Rheumatol 2017 05;44(5):668-673

From the Rheumatology Research Unit, Cambridge University Hospitals UK National Health Service (NHS) Foundation Trust, Cambridge; UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals NHS Foundation Trust, Bradford, UK; Department of Medicine, Division of Rheumatology, University of Toronto, Toronto Western Hospital, Krembil Research Institute; Division of Dermatology, Toronto Western Hospital, University of Toronto, Ontario; University of Alberta, Edmonton, Alberta, Canada; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington; Advisory Services, QuintilesIMS, Denver, Colorado; Duke University School of Medicine, Durham, North Carolina; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester; New York Medical College, Valhalla; Hofstra Northwell School of Medicine, New Hyde Park, New York, New York; Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Cleveland Clinic, Cleveland, Ohio; University of Utah, Salt Lake City, Utah; University of Southern California, Los Angeles; University of California at San Diego, San Diego, California, USA; Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; Division of Rheumatology, University of Cagliari, Cagliari, Italy, Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Federal University of Paraná, Curitiba, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170141DOI Listing
May 2017

Defining Outcome Measures for Psoriatic Arthritis: A Report from the GRAPPA-OMERACT Working Group.

J Rheumatol 2017 05;44(5):697-700

From Medicine and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; University of Utah, Salt Lake City, Utah; QuintilesIMS, Denver, Colorado; Duke University School of Medicine, Durham, North Carolina; Rheumatology Research, Swedish Medical Center; University of Washington School of Medicine, Seattle, Washington; International Dermatology Outcome Measurers, West Granby, Connecticut; Cleveland Clinic, Cleveland, Ohio; Division of Immunology/Rheumatology, Stanford University School of Medicine, Palo Alto, California; Johns Hopkins University School of Medicine; Psoriatic Arthritis Program, Johns Hopkins Arthritis Center, Baltimore, Maryland, USA; VU Medical Centre, Amsterdam, the Netherlands; University of Toronto; Krembil Research Institute; Psoriatic Disease Program, Toronto Western Hospital; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada; Hong Kong Psoriatic Arthritis Association, Hong Kong, China; UK National Institute for Health Research (NIHR), Leeds; Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Royal United Hospital; Royal United Hospital; Pharmacy and Pharmacology, University of Bath, UK; Newman Clinical Research Professor, St. Vincent's University Hospital and University College Dublin; Our Lady's Hospice and Care Services, Dublin, Ireland; Internal Medicine, Division of Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605807PMC
May 2017

GRAPPA 2016 Project Report.

J Rheumatol 2017 05;44(5):706-710

From the UK National Institute for Health Research (NIHR); Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals UK National Health Service (NHS) Foundation Trust, Bradford, UK; Department of Rheumatology, St. Vincent's University Hospital; Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Utah, Salt Lake City, Utah; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.170153DOI Listing
May 2017

Perceptions of the Cause, Impact and Management of Persistent Fatigue in Patients with Rheumatoid Arthritis Following Tumour Necrosing Factor Inhibition Therapy.

Musculoskeletal Care 2017 03 12;15(1):23-35. Epub 2016 Feb 12.

School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/msc.1136DOI Listing
March 2017

Effects of targeted therapies on the bone in arthritides.

Autoimmun Rev 2017 Mar 31;16(3):313-320. Epub 2017 Jan 31.

University of Debrecen Faculty of Medicine, Department of Rheumatology, Hungary. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.autrev.2017.01.014DOI Listing
March 2017

Psoriatic arthritis: complexities, comorbidities and implications for the clinic.

Expert Rev Clin Immunol 2016 28;12(4):405-16. Epub 2016 Jan 28.

b Department of Rheumatology , St Vincent's University Hospital , Dublin , Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/1744666X.2016.1139453DOI Listing
December 2016

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?

Semin Arthritis Rheum 2016 12 2;46(3):291-304. Epub 2016 Jun 2.

Larrey Hospital, Paul Sabatier University, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.semarthrit.2016.05.012DOI Listing
December 2016

Implications of the diversity of class I HLA associations in psoriatic arthritis.

Clin Immunol 2016 Nov 25;172:29-33. Epub 2016 Jul 25.

Department of Rheumatology, St. Vincent's University Hospital and Conway Institute, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clim.2016.07.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159216PMC
November 2016

Replication of a distinct psoriatic arthritis risk variant at the IL23R locus.

Ann Rheum Dis 2016 07 25;75(7):1417-8. Epub 2016 Mar 25.

Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, The University of Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust and University of Manchester, Manchester Academy of Health Sciences, Manchester, UK The Kellgren Centre for Rheumatology, Central Manchester Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-209290DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941176PMC
July 2016

A clinically based protein discovery strategy to identify potential biomarkers of response to anti-TNF-α treatment of psoriatic arthritis.

Proteomics Clin Appl 2016 06 28;10(6):645-62. Epub 2015 Sep 28.

School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201500051DOI Listing
June 2016

Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discovery.

Proteomics Clin Appl 2016 06 9;10(6):691-8. Epub 2015 Nov 9.

School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.201500046DOI Listing
June 2016

Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting.

J Rheumatol 2016 05;43(5):965-9

From the Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA; VU Medical Centre, Amsterdam, The Netherlands, Division of Rheumatology, Johns Hopkins University, Baltimore, Maryland, USA; Department of Internal Medicine, Division of Rheumatology, Hacettepe University Ankara, Ankara, Turkey; Toronto Western Hospital, Toronto, Ontario, Canada; Royal National Hospital for Rheumatic Diseases, Bath, UK; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto, Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Quintiles, Duke University School of Medicine, Durham, North Carolina, USA; Sorbonne Universités, UPMC Univ Paris 06, Institut Pierre Louis d'Epidémiologie et de Santé Publique, GRC-UPMC 08 (EEMOIS); AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Cleveland Clinic, Cleveland, Ohio, USA; University of Leeds, Leeds, UK, and Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Division of Immunology, Stanford University, Palo Alto, California, USA; University of Pennsylvania, Philadelphia, Pennsylvania, USA.A.M. Orbai, MD, MHS, Division of Rheumatology, Johns Hopkins University; P.J. Mease, MD, Rheumatology Research, Swedish Medical Center and University of Washington School of Medicine; M. de Wit, PhD, Patient Research Partner, VU Medical Centre; U. Kalyoncu, MD, Division of Rheumatology, Johns Hopkins University and Department of Internal Medicine, Division of Rheumatology, Hacettepe University Ankara; W. Campbell, BEd LLB, Patient Research Partner, Toronto Western Hospital; W. Tillett, BSc, MB, ChB, PhD, MRCP, Royal National Hospital for Rheumatic Diseases; L. Eder, MD, PhD, Toronto We

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.160116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5235387PMC
May 2016

GRAPPA 2015 Research and Education Project Reports.

J Rheumatol 2016 05;43(5):979-85

From the Swedish Medical Center, and the University of Washington School of Medicine, Seattle, Washington, USA; University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Geneva University Hospital, Geneva, Switzerland; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland; University of Toronto and Krembil Research Institute, Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; Rheumatology and Immunology, Oregon Health and Science University, Portland, Oregon; University of Utah, Salt Lake City, Utah, USA.P.J. Mease, MD, Rheumatology Research, Swedish Medical Center, and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds, and Bradford Hospitals NHS Foundation Trust; W.H. Boehncke, MD, Geneva University Hospital; L.C. Coates, MBChB, PhD, UK National Institute for Health Research Clinical Lecturer, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; O. FitzGerald, MD, FRCPI, FRCP( UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital, and Conway Institute for Biomolecular Research, University College Dublin; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto, Senior Scientist, Krembil Research Institute, and Director, Psoriatic Arthritis Program, University Health Network; A.A. Deodhar, MD, MRCP, FACP, FACR, Medical Director, Rheumatology and Immunology, Oregon Health and Science University; K. Callis Duffin, MD, University of Utah.

View Article

Download full-text PDF

Source
http://www.jrheum.org/cgi/doi/10.3899/jrheum.160119
Publisher Site
http://dx.doi.org/10.3899/jrheum.160119DOI Listing
May 2016

Spondyloarthropathies: IL-6 blockade in psoriatic arthritis - a new therapeutic option?

Nat Rev Rheumatol 2016 05;12(6):318-9

Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2016.84DOI Listing
May 2016

Improving recognition of spondyloarthropathy in primary care: an unmet need.

Ann Rheum Dis 2016 Apr 28;75(4):e19. Epub 2016 Jan 28.

Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2016-209118DOI Listing
April 2016

Higher Prevalence of Metabolic Syndrome in Patients with Psoriatic Arthritis: A Comparison with a Control Group of Noninflammatory Rheumatologic Conditions.

J Rheumatol 2016 Feb;43(2):463-4

Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.150757DOI Listing
February 2016

Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter--Determining Validation Requirements.

J Rheumatol 2016 Jan 1;43(1):208-13. Epub 2015 Jun 1.

From the Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute at Barts, and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK; Rheumatology and Translational Immunology Research Laboratories (LaRIT), Division of Rheumatology, IRCCS Policlinico San Matteo Foundation/University of Pavia, Pavia, Italy; Rheumatology Research Group, School of Immunity and Infection, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK; Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, and Rheumatology Department, Lisbon Academic Medical Centre, Lisbon, Portugal; Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain and Department of Rheumatology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Rheumatology Department, Ambroise Paré Hospital, APHP, Université Versailles Saint Quentin en Yvelines, Inserm U987, Boulogne-Billancourt, France; Rheumatology Department, Hospital Universitario Severo Ochoa, Madrid, Spain; Laboratory for Skeletal Development and Joint Disorders, Department of Development and Regeneration, KU Leuven, Leuven, Belgium; University of Cambridge, Cambridge, UK; GlaxoSmithKline Research and Development, Stevenage, UK; School of Medicine and Medical Science, St. Vincent's University Hospital, Dublin, Ireland; Rheumatology Research Unit, Repatriation General Hospital, Daw Park, South Australia; Dublin Academic Medical Centre, The Conway Institute of Biomedical and Biomolecular Research, University College Dublin, Dublin, Ireland; Cardiff Institute of Infection and Immunity, Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre, Cardiff, UK; Division of Immunology/Rheumatology, Stanford University School of Medicine, Stanford, California, USA.F. Humby, MRCP; S. Kelly, MRCP, Centre for Experimental Medicine and Rheumatology, William Harvey Research Ins

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141199DOI Listing
January 2016

Peripheral joint involvement in psoriatic arthritis patients.

Clin Exp Rheumatol 2015 Sep-Oct;33(5 Suppl 93):S26-30. Epub 2015 Oct 15.

Department of Rheumatology, St Vincent's University Hospital, Elm Park, Dublin, Ireland.

View Article

Download full-text PDF

Source
December 2015

Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.

J Rheumatol 2015 Nov 1;42(11):2198-203. Epub 2015 May 1.

From the Royal National Hospital for Rheumatic Diseases, Bath, UK; Toronto Western Hospital; Psoriatic Arthritis Program, University Health Network, Toronto Western Research Institute, Toronto, Ontario, Canada; St. Vincent's University Hospital, Dublin, Ireland; Quintiles; Duke University School of Medicine; Durham, North Carolina, USA; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; Chapel Allerton Hospital, Leeds, UK; Sorbonne Universités, Université Pierre et Marie Curie-Paris 6 (UPMC Univ Paris 6), Institut Pierre Louis d'Epidémiologie et de Santé Publique; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Johns Hopkins University School of Medicine, Division of Rheumatology, Baltimore, Maryland; Division of Immunology/Rheumatology, Stanford University School of Medicine, Portola Valley, California, USA; University of Bath, Bath, UK; Swedish Medical Center, University of Washington, Seattle, Washington; Hospital of the University of Pennsylvania (HUP), Philadelphia, Pennsylvania, USA.W. Tillett, MB, ChB, BSc, MRCP, PhD, Research Fellow, Royal National Hospital for Rheumatic Diseases; L. Eder, MD, PhD, Postdoctoral Research Fellow, Toronto Western Hospital; M. de Wit, PhD, OMERACT Patient Research Partner, The Netherlands; D.D. Gladman, MD, FRCPC, Director, Psoriatic Arthritis Program, University Health Network, Senior Scientist, Toronto Western Research Institute; O. FitzGerald, MD, FRCPI, FRCP( UK), Consultant Rheumatologist and Newman Clinical Research Professor, St. Vincent's University Hospital; N. Goel, MD, OMERACT Patient Research Partner, Quintiles, and Duke University School of Medicine; W. Campbell, BEd, LLB, OMERACT Patient Research Partner; P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Chapel Allerton Hospital; L. Gossec, MD, PhD, Sorbonne Universités, UPMC Univ Paris 6, Institut Pierre Louis d'Epidémiologie et de Sant

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.141156DOI Listing
November 2015

PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus.

Ann Rheum Dis 2015 Oct 28;74(10):1882-5. Epub 2015 Apr 28.

Arthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Institute for Inflammation and Repair, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK The Kellgren Centre for Rheumatology, Central Manchester Foundation Trust, NIHR Manchester Biomedical Research Centre, Manchester, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/annrheumdis-2014-207187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602265PMC
October 2015

Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis.

Ann Rheum Dis 2015 Jun 13;74(6):1045-50. Epub 2014 Feb 13.

Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://ard.bmj.com/lookup/doi/10.1136/annrheumdis-2013-20485
Publisher Site
http://dx.doi.org/10.1136/annrheumdis-2013-204858DOI Listing
June 2015

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis.

Arthritis Res Ther 2015 Jun 1;17:141. Epub 2015 Jun 1.

Conway Institute of Biomedical Research, University College Dublin, Belfield, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-015-0652-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450469PMC
June 2015

Psoriatic arthritis under a proteomic spotlight: application of novel technologies to advance diagnosis and management.

Curr Rheumatol Rep 2015 May;17(5):35

School of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11926-015-0509-0DOI Listing
May 2015

Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype.

Arthritis Res Ther 2015 May 7;17:115. Epub 2015 May 7.

Rheumatology Division, Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York City, NY, 10032, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13075-015-0640-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422545PMC
May 2015

Profound reduction in hospital admissions and musculoskeletal surgical procedures for rheumatoid arthritis with concurrent changes in clinical practice (1995-2010).

Rheumatology (Oxford) 2015 Apr 22;54(4):666-71. Epub 2014 Sep 22.

Department of Rheumatology and Department of Orthopaedic Surgery, St. Vincent's University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/keu340DOI Listing
April 2015

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Nat Commun 2015 Feb 5;6:6046. Epub 2015 Feb 5.

1] Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Manchester M13 9PT, UK [2] NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester Foundation Trust and University of Manchester, Manchester Academy of Health Sciences, Manchester M13 9WU, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4327416PMC
February 2015

Drug therapies for peripheral joint disease in psoriatic arthritis: a systematic review.

J Rheumatol 2014 Nov;41(11):2277-85

From the Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires; Academic Unit of Rheumatology, Universidade Federal de Uberlândia, Uberlândia, MG, Brazil; Section of Rheumatology, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA; Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds, UK; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College, Dublin, Ireland; Department of Pharmacy and Pharmacology, University of Bath, Bath, UK; Barking Havering and Redbridge University Hospitals, NHS Trust; and Queens Mary's University of London, London, UK; and Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA.M.L. Acosta Felquer, MD, Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires; L.C. Coates, MRCP, PhD, NIHR Clinical Lecturer, Leeds Institute; E.R. Soriano, MD, MSC, Jefe Sección Reumatología, Servicio de Clínica Médica, Hospital Italiano de Buenos Aires; R. Ranza, MD, Academic Unit of Rheumatology, Universidade Federal de Uberlândia; L.R. Espinoza, MD, Section of Rheumatology, Louisiana State University Health Sciences Center; P.S. Helliwell, DM, PhD, Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital; O. FitzGerald, MD, Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College; N. McHugh, FRCP, MD, Department of Pharmacy and Pharmacology, University of Bath; E. Roussou, MD, Consultant Rheumatologist, Barking Havering and Redbridge University Hospitals, NHS Trust and Clinical Senior Lecturer, Queens Mary's University of London; P.J. Mease, MD, Rhe

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140876DOI Listing
November 2014

Sustained remission with etanercept tapering in early rheumatoid arthritis.

N Engl J Med 2014 Nov;371(19):1781-92

From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, the Chapel Allerton Hospital, and the National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust - all in Leeds, United Kingdom (P.E., M.H.B.); Hamad Medical, Doha, Qatar (M.H.); St. Vincent's University Hospital, Dublin (O.F.); Rheumatology Department, Lapeyronie Hospital, Montpellier 1 University, Montpellier, France (B.C.); La Paz University Hospital, IdiPaz, Madrid (E.M.-M.); Hospital Health Center of West Mazovia, Rheumatology Department, Żyrardów, Poland (M.K.); and Pfizer, Collegeville, PA (T.W., S.G., R.P., J.B., B.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1316133DOI Listing
November 2014

Spondyloarthropathies: Apremilast: welcome advance in treatment of psoriatic arthritis.

Nat Rev Rheumatol 2014 Jul 20;10(7):385-6. Epub 2014 May 20.

Rheumatology Group, St Vincent's University Hospital, Elm Park, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrrheum.2014.77DOI Listing
July 2014

High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease.

J Rheumatol 2014 Jul 15;41(7):1357-65. Epub 2014 Jun 15.

From the Department of Rheumatology and Department of Diagnostic Imaging, St. Vincent's University Hospital, Dublin, Ireland.M. Haroon, MB, MMedSc, MRCPI; P. Gallagher, RGN, Department of Rheumatology; E. Heffernan, MB, BCh, MRCSI, FFRRCSI, Department of Diagnostic Imaging; O. FitzGerald, MD, FRCPI, FRCP (UK), professor, Department of Rheumatology, St. Vincent's University Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140021DOI Listing
July 2014

Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 Annual Meeting.

J Rheumatol 2014 Jun;41(6):1206-11

From the Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin, Ireland; University of Toronto; Toronto Western Research Institute; Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada; University of Leeds, Leeds, UK; Royal National Hospital for Rheumatic Diseases, UK National Health Service (NHS) Foundation Trust, Bath, UK; Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA; Johns Hopkins Arthritis Center, Baltimore, Maryland, USA; Rheumatology Department, Hospital de Clinicas de Porto Alegre, Brazil; Royal National Hospital for Rheumatic Diseases, Bath, UK.M. de Wit, PhD, Patient Research Partner, Amsterdam, The Netherlands; W. Campbell, BA, BEd, LLB, Patient Research Partner, Toronto, Ontario, Canada; O. FitzGerald, MD, FRCPI, FRCP(UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Senior Scientist, Toronto Western Research Institute and Director, Psoriatic Arthritis Program, University Health Network; P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds; J. James, Patient Research Partner, Bath, UK; C. Lindsay, Patient Research Partner, Thousand Oaks, California, USA; R. MacDonald, Patient Research Partner, Toronto, Ontario, Canada; N.J. McHugh, MBChB, MD, FRCP, FRCPath, Royal National Hospital for Rheumatic Diseases, NHS Foundation Trust; P.J. Mease, MD, Director, Rheumatology Research, Swedish Medical Center, Clinical Professor, University of Washington School of Medicine; A-M. Orbai, MD, MHS, Johns Hopkins Arthritis Center; P. Palominos, MD, Rheumatology Department, Hospital de Clinicas de Porto Alegre; A. Parkinson, Patient Research Partner, Leeds, UK; W. Tillett, BSc, MBChB, MRCP, Royal National Hospital for Rheumatic Diseases; N. Goel, MD, Patient Research Partner, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140171DOI Listing
June 2014

Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response.

J Rheumatol 2014 Jun;41(6):1212-7

From the University of Leeds, Leeds, UK, and Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford, UK; Department of Rheumatology, St. Vincent's University Hospital, Elm Park, Dublin, Ireland; Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands.P.S. Helliwell, DM, PhD, FRCP, Senior Lecturer in Rheumatology, University of Leeds and Bradford Hospitals NHS Foundation Trust; O. FitzGerald, MD, FRCPI, FRCP(UK), Newman Clinical Research Professor, Department of Rheumatology, St. Vincent's University Hospital; J. Fransen, PhD, Department of Rheumatology, Radboud University Medical Centre.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140172DOI Listing
June 2014

GRAPPA 2013 Annual Meeting, rheumatology updates: psoriatic arthritis (PsA) biomarker project, arthritis mutilans, PsA-peripheral spondyloarthritis epidemiology project.

J Rheumatol 2014 Jun;41(6):1244-8

From the Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College, Dublin, Ireland; Rheumatology Research, Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA; Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital, Leeds, UK; Division of Rheumatology, Department of Medicine, University of Toronto; Centre for Prognostic Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.O. FitzGerald, MD, Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College; P.J. Mease, MD, Rheumatology Research, Swedish Medical Center and Clinical Professor, University of Washington School of Medicine; P.S. Helliwell, DM, PhD, Academic Unit of Musculoskeletal Disease, Chapel Allerton Hospital; V. Chandran, MBBS, MD, DM, PhD, Division of Rheumatology, Department of Medicine, University of Toronto, and Centre for Prognostic Studies in the Rheumatic Diseases, Toronto Western Hospital, University Health Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.140181DOI Listing
June 2014

Editorial: emerging evidence for critical involvement of the interleukin-17 pathway in both psoriasis and psoriatic arthritis.

Arthritis Rheumatol 2014 May;66(5):1077-80

St. Vincent's University Hospital, The Conway Institute, and University College Dublin, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/art.38370
Publisher Site
http://dx.doi.org/10.1002/art.38370DOI Listing
May 2014

Development of a disease activity and responder index for psoriatic arthritis--report of the Psoriatic Arthritis Module at OMERACT 11.

J Rheumatol 2014 Apr 1;41(4):782-91. Epub 2014 Feb 1.

From the Division of Rheumatic and Musculoskeletal Disease, University of Leeds, UK; Department of Rheumatology, St. Vincent's University Hospital and Conway Institute, University College Dublin, Dublin, Ireland; Seattle Rheumatology Associates, Swedish Medical Center, University of Washington School of Medicine, Seattle, Washington, USA; Division of Rheumatology, Department of Medicine, University of Toronto, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada; Division of Immunology/Rheumatology, Stanford University, Palo Alto, California; Division of Rheumatology, Department of Medicine, Duke University Medical Center, Durham, and General Medicine Therapeutic Delivery Unit, Quintiles, Morrisville, North Carolina; Department of Dermatology, University of Utah, Salt Lake City, Utah, USA; Royal National Hospital for Rheumatic Diseases and University of Bath, Bath, UK.

View Article

Download full-text PDF

Source
http://www.jrheum.org/content/41/4/782.full.pdf
Web Search
http://www.jrheum.org/cgi/doi/10.3899/jrheum.131250
Publisher Site
http://dx.doi.org/10.3899/jrheum.131250DOI Listing
April 2014

Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis?

Clin Exp Rheumatol 2013 Jul-Aug;31(4 Suppl 78):S54-8. Epub 2013 Oct 4.

Academic Rheumatology Unit, Department of Medicine and Health Sciences, University of Molise, Campobasso, Italy.

View Article

Download full-text PDF

Source
December 2013

Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity.

Am J Pathol 2013 Oct 6;183(4):1243-1257. Epub 2013 Aug 6.

UCD Veterinary Sciences Centre, University College Dublin, Belfield, Ireland; Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Belfield, Ireland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2013.06.029DOI Listing
October 2013

Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment.

Rheumatology (Oxford) 2013 Sep 16;52(9):1572-82. Epub 2013 May 16.

Department of Rheumatology, Dublin Academic Medical Centre, Dublin 4, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/rheumatology/ket189DOI Listing
September 2013

Biomarkers: project update from the GRAPPA 2012 annual meeting.

J Rheumatol 2013 Aug;40(8):1453-4

Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3899/jrheum.130462DOI Listing
August 2013